Molecular genetics of AMD and current animal models

被引：78

作者：

Edwards A.O. ^{[1
]}

Malek G. ^{[2
]}

机构：

[1] Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905, 200 First Street, SW

[2] Albert Eye Research Institute, Duke University, Durham, NC 27710, Erwin Road

来源：

Angiogenesis | 2007年 / 10卷 / 2期

关键词：

Animal model; Eye; Gene; Genetic association; Macular degeneration; Retina; SNP;

D O I：

10.1007/s10456-007-9064-2

中图分类号：

学科分类号：

摘要：

During the past few years systematic investigation into the epidemiology, genetics, and pathophysiology of age-related macular degeneration (AMD) has provided important new insight into this leading cause of vision loss in older persons. These studies provide a view of AMD as a complex trait influenced by well-established genetic and environmental risks that leads to the deposition of inflammatory deposits in the outer retina. This maculopathy leads to visual dysfunction through a variety of mechanisms and complications that can be observed in both humans and animal models. In this review, the risks associated with AMD in humans and the animal models used to study AMD and its complications will be summarized. No effort has been made to perform a comprehensive citation of all areas of AMD genetics and animal models, but rather a selection of observations and supporting references illustrative of the current state of the field is presented. © 2007 Springer Science + Business Media B.V.

引用

页码：119 / 132

页数：13

共 111 条

[1]

Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V., A role for local inflammation in the formation of drusen in the aging eye, Am J Ophthalmol, 134, pp. 411-431, (2002)

[2]

Johnson L.V., Anderson D.H., Age-related macular degeneration and the extracellular matrix, N Engl J Med, 351, pp. 320-322, (2004)

[3]

Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., Mullins R.F., An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration, Prog Retin Eye Res, 20, pp. 705-732, (2001)

[4]

Crabb J.W., Miyagi M., Gu X., Et al., Drusen proteome analysis: An approach to the etiology of age-related macular degeneration, Proc Natl Acad Sci USA, 99, pp. 14682-14687, (2002)

[5]

Curcio C.A., Medeiros N.E., Millican C.L., The alabama age-related macular degeneration grading system for donor eyes, Invest Ophthalmol Vis Sci, 39, pp. 1085-1096, (1998)

[6]

Klein R., Davis M.D., Magli Y.L., Segal P., Klein B.E., Hubbard L., The Wisconsin age-related maculopathy grading system, Ophthalmology, 98, pp. 1128-1134, (1991)

[7]

Bird A.C., Bressler N.M., Bressler S.B., Et al., An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group, Surv Ophthalmol, 39, pp. 367-374, (1995)

[8]

Olsen T.W., Feng X., The Minnesota Grading System of eye bank eyes for age-related macular degeneration, Invest Ophthalmol Vis Sci, 45, pp. 4484-4490, (2004)

[9]

Ferris F.L., Davis M.D., Clemons T.E., Et al., A simplified severity scale for age-related macular degeneration: AREDS Report No. 18, Arch Ophthalmol, 123, pp. 1570-1574, (2005)

[10]

Davis M.D., Gangnon R.E., Lee L.Y., Et al., The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17, Arch Ophthalmol, 123, pp. 1484-1498, (2005)

← 1 2 3 4 5 6 7 8 9 10 →